Top Buy
| Wertpapier | Buy | Sell | Buy (1M) | Sell (1M) | Kurs | Kursziel | Potential |
|---|---|---|---|---|---|---|---|
| Eli Lilly Corp. | 51 | 0 | 6 | 0 | 739,60 € | 776,16 € | 4,94 % |
| Biogen Inc. | 47 | 1 | 7 | 1 | 207,20 € | 294,01 € | 41,90 % |
| Vertex Pharmaceuticals Inc. | 46 | 2 | 6 | 0 | 413,45 € | 409,07 € | -1,06 % |
| Alnylam Pharmace. | 36 | 0 | 2 | 0 | 137,60 € | 236,30 € | 71,73 % |
| Regeneron Pharmaceuticals Inc. | 36 | 1 | 4 | 0 | 915,20 € | 959,41 € | 4,83 % |
| Johnson & Johnson | 34 | 1 | 3 | 0 | 141,92 € | 195,83 € | 37,99 % |
| Neurocrine Bioscience | 29 | 0 | 8 | 0 | 129,55 € | 140,60 € | 8,53 % |
| Merck & Co. Inc. | 28 | 1 | 1 | 0 | 121,20 € | 124,93 € | 3,08 % |
| Cytokinetics Inc. | 27 | 1 | 4 | 0 | 54,50 € | 85,64 € | 57,14 % |
| Amgen Inc. | 25 | 0 | 4 | 0 | 288,20 € | 297,31 € | 3,16 % |
| Intra-Cellular Therapies Inc. | 25 | 0 | 5 | 0 | 63,00 € | 79,55 € | 26,28 % |
| Pfizer Inc. | 28 | 4 | 1 | 0 | 27,03 € | 40,66 € | 50,45 % |
| AbbVie Inc. | 22 | 0 | 4 | 0 | 148,20 € | 175,11 € | 18,16 % |
| Zoetis Inc. A | 23 | 1 | 4 | 0 | 158,76 € | 200,06 € | 26,01 % |
| Sutro Biopharma Inc | 21 | 0 | 3 | 0 | 4,32 € | 11,04 € | 155,61 % |
| United Therapeutics | 19 | 0 | 4 | 0 | 253,50 € | 287,40 € | 13,37 % |
| Pacira Pharmaceuticals | 18 | 0 | 3 | 0 | 27,80 € | 47,53 € | 70,96 % |
| Exelixis Inc. | 18 | 0 | 3 | 0 | 19,13 € | 26,01 € | 35,98 % |
| TG Therapeutics Inc. | 22 | 4 | 2 | 0 | 15,30 € | 28,06 € | 83,48 % |
| Iovance Biotherapeutics Inc. | 20 | 3 | 1 | 0 | 9,52 € | 22,78 € | 139,24 % |
| Natural Alternat. | 18 | 1 | 1 | 0 | 5,90 € | - | - |
| Insmed Inc. | 18 | 1 | 6 | 1 | 22,60 € | 44,16 € | 95,42 % |
| Krystal Biotech | 17 | 0 | 2 | 0 | 154,75 € | 179,60 € | 16,05 % |
| EyePoint Pharmaceuticals Inc. | 18 | 1 | 4 | 0 | 10,88 € | 27,80 € | 155,55 % |
| Abbott Laboratories | 16 | 0 | 0 | 0 | 96,14 € | 116,71 € | 21,40 % |